INTERCEPT PHARMACEUTICALS INC

51 Belcher Holw, Berlin, Connecticut, United States

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

25.0%

Phase 1

25.0%

Trial Status Distribution

Active, not recruiting

75.0%

Completed

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Pilot Study Of Obeticholic Acid In Portal Hypertensio

Active, not recruiting

Jul 201378 participants

Pilot Study Of Obeticholic Acid In Portal Hypertensio

Phase 1

Active, not recruiting

Aug 201278 participants

A preliminary study to examine and evaluate the effect of obeticholic acid (INT-747) for the treatment of portal hypertension in patients with alcoholic liver disease

Not Applicable

Completed

interventional

Jul 201134 participants

An Early Stage Study to Evaluate the Safety, Tolerability and Efficacy of the Medicinal Product Obeticholic Acid for the Treatment of Portal Hypertension, a liver disease.

Active, not recruiting

Dec 201078 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations